How to Surface Leadership Blind Spots in Major Decisions

Most bad decisions at the top of financial services firms are not caused by missing information. They are caused by information that was present but discounted, dissent that was polite but ignored, and confidence that grew faster than evidence. Blind spots in major decisions, acquisitions, market entries, systems overhauls, senior hires, capital actions, are rarely random. They follow patterns, and those patterns can be worked against deliberately.

Key Executive Takeaways

• Leadership blind spots are structural, not personal: they emerge from how information reaches the top, who challenges whom, and what the group rewards, so the fix has to be built into the decision process itself.
• The highest-risk decisions are the ones where the executive sponsor is most personally invested, the timeline is compressed, and the dissenting voices are junior, external, or absent.
• A disciplined pre-decision review, covering assumptions, disconfirming evidence, second-order consequences, and stakeholder reactions, catches more errors than any post-mortem ever will.

Where Blind Spots Actually Come From

Three sources dominate. The first is filtered information: by the time a proposal reaches the board or executive committee, it has been shaped by people whose careers depend on its approval. Caveats soften, ranges narrow, and the paper reads as a recommendation rather than a decision. The second is social conformity: in a room of senior peers, the cost of being the lone sceptic is high, particularly when the CEO has signalled a preference. The third is pattern-matching from prior success: executives who built their reputations in one cycle, product, or jurisdiction over-apply that experience to situations that differ in ways that matter.

In regulated firms, a fourth source matters: the assumption that compliance sign-off equals decision quality. Legal and compliance functions confirm a course of action is permissible. They do not confirm it is wise.

The Decisions Most at Risk

Blind spots concentrate around a predictable set of conditions. Watch for any decision where the sponsor has publicly committed to the outcome, where the analysis has been produced entirely inside the sponsoring team, where the timeline is being driven by an external counterparty or market window, or where the downside scenarios in the paper feel implausibly mild. Add to that any decision touching a domain where the executive team has limited direct experience: a new customer segment, a novel technology stack, an unfamiliar jurisdiction, or a regulatory regime the firm has not operated under before.

When two or more of these conditions are present, treat the decision as high-risk regardless of its financial size.

What Good Looks Like: A Pre-Decision Review

Before any material decision is signed off, run a structured challenge session separate from the main approval meeting. It should cover four things.

Assumptions on the page. List the three or four assumptions that, if wrong, break the case. Ask what evidence would tell you they are wrong, and whether anyone has looked for that evidence.

Disconfirming views. Identify who inside the firm would most likely disagree with the recommendation and why. If no one has been asked, that is the finding. External voices, an independent adviser, a former regulator, a customer, often surface what internal reviewers cannot.

Second-order consequences. Walk through what happens twelve and twenty-four months after the decision, not just at close. Which teams inherit the operational burden? What does the firm stop doing to make room? How does the regulator see the cumulative shape of the firm's activity?

Stakeholder reactions. Map how key stakeholders, supervisors, rating agencies, major shareholders, staff, will actually respond, not how the firm hopes they will. If the plan depends on a benign reaction that has not been tested through prior soundings, mark it as an open risk.

What Most People Get Wrong

Firms confuse debate with challenge. A lively discussion in which everyone agrees on the fundamentals is not challenge. Real challenge means someone in the room is prepared to say the recommendation is wrong and to explain why, without career consequence. If the culture does not permit that, no framework will compensate.

The second common error is treating the pre-mortem as a formality. A pre-mortem run in fifteen minutes at the end of a three-hour meeting produces nothing useful. Give it its own session, its own preparation, and its own written output.

Your Next Move

Pick the next material decision on your committee agenda. Before it is tabled, commission a written pre-decision review covering the four areas above, produced by someone with no stake in the outcome. Read it before you read the recommendation. That single change surfaces more blind spots than any training programme.

Frequently Asked Questions

Who should run the pre-decision review?

Ideally someone senior enough to be taken seriously but outside the sponsoring line: a non-executive director, the chief risk officer, or an independent adviser. Internal audit is often too downstream. The reviewer needs standing to push back on the CEO if required.

How do we stop this becoming a bureaucratic hurdle?

Reserve it for decisions that meet a clear threshold: material capital commitment, entry or exit from a business line, senior appointments to regulated roles, or anything that changes the firm's risk profile. Routine decisions should not trigger it.

What if the CEO is the source of the blind spot?

That is what the chair and senior independent director are for. If the board cannot challenge the CEO on a major decision, the problem is governance, not process, and it needs to be addressed directly rather than worked around.

How do we handle time pressure from counterparties?

Treat externally imposed deadlines with suspicion. Genuine deals survive a week of proper diligence. Deals that do not are usually the ones you should not do.